latisse

Policy & Practice

November 30, 2009 · Posted in Healh News 

Can’t get enough Policy & Practice? Check out our new podcast each Monday. egmnblog.wordpress.com Allergan just reported its third-quarter earnings, and although Botox (onabotulinumtoxinA) sales increased a scant 3%, the company said that the injectable contributed to a net profit rise of 8.3%.

View original post here:
Policy & Practice

Comments

Leave a Reply